JSC Grindeks has received the high evaluation for the previous business achievements and capability to hold the position as the leading pharmaceutical company in the Baltic States. The experts have also noted the orientation of Grindeks business activities towards the major shareholders, the strong product brand Mildronate® and the successful geographical diversification. To keep the honour of the best listed company in Latvia for the third year also helped such corporate quality criteria as business model, transparency and corporate governance that turn JSC Grindeks into an attractive investment object.

The annual “Baltic Corporate Excellence Award” survey is made by the financial research company “CE Services”, in order to nominate the best listed company in the Baltic States and the best companies in each of the countries, as well as to motivate other companies to improve their corporate qualities such as financial state, management quality, etc.

For the best listed company in the Baltic States is nominated the Lithuanian telecommunications company “Teo LT” that has also won among listed companies in Vilnius. In Estonia has won the water company “Tallinna Vesi”.

On Grindeks

Grindeks is the leading pharmaceutical company in the Baltic States. Its main fields of action are: research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients. Grindeks specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups.

The Group of Grindeks consists of four subsidiary companies in Latvia, Estonia and Russia, as well representatives and representative offices in fourteen countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are: the Baltic States, Russia and other CIS countries, Japan and the USA. JSC Grindeks shares are listed on the Official List of “Nasdaq OMX Riga”.

Further information:
Laila Klavina
Head of the Communications Department, JSC Grindeks
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
e-mail: [email protected]